Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Didecyldimethylammonium chloride (DDAC) is a quaternary ammonium compound widely used as an antiseptic and disinfectant. It acts as a broad-spectrum biocidal agent against bacteria and fungi by disrupting intermolecular interactions and dissociating lipid bilayers in microbial cell membranes. Its bacteriostatic or bactericidal activity depends on concentration and the growth phase of the target microorganisms. DDAC is commonly used for surface disinfection in hospitals, hotels, industries, gynecology, surgery, ophthalmology, pediatrics, sterilization of surgical instruments and endoscopes. It is also found in veterinary disinfectants. Mechanistically, it targets microbial cell membranes leading to their disruption[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on didecyldimethylammonium chloride.